Answers are grounded in this paper and cite their sources.
Background The Coronavirus Disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) virus, has emerged as a global health crisis. While primarily known for its respiratory symptoms, COVID-19 can also manifest with a wide range of extrapulmonary complications, including hematological disorders. Case report This case involves an otherwise healthy 8-year-old child who was admitted to the hospital with symptoms of irritability, fatigue, and red-coloured urine lasting for one day. He was found to be hemodynamically stable, though laboratory tests revealed low hemoglobin levels with signs consistent with hemolysis. A COVID-19 PCR test returned positive. After ruling out immune-mediated causes of hemolysis, a diagnosis of non-immune hemolytic anemia associated with COVID-19 infection was established. The patient was successfully treated with a blood transfusion and supportive measures, leading to a complete recovery. This case highlights the potential for COVID-19 to trigger non-immune hemolytic anemia in pediatric patients. Conclusion Hemolytic anemia following COVID-19, as an extrapulmonary complication, can manifest as either immune-mediated or non-immune hemolysis. Both forms of Hemolytic anemia in COVID-19 have been observed to respond rapidly to symptomatic treatment, underscoring the significance of prompt therapeutic intervention in managing this rare hematologic complication.
No takes yet. Share an insight, caveat, or question.
Karar et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: